Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-11-21

Clinical Trial Update: IV Iron vs Oral Iron for Treatment of Anemia in Women With Abnormal Uterine Bleeding [Phase 4]

View source ↗

Summary

Phase 4 trial comparing IV iron to oral iron for anemia in women with abnormal uterine bleeding; status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IV iron
  • Oral iron (ferrous sulfate)

Snippet

Sponsor: Thomas Jefferson University | Conditions: Anemia, Iron Deficiency, Heavy Menstrual Bleeding | Phase 4 | Status: UNKNOWN